Glucose 6 Phosphate Dehydrogenase (G6PD) Quantitative Biomarker Testing
It measures your red blood cells’ G6PD enzyme activity to assess hemolysis risk; order through Vitals Vault and test at a Quest location.
With Vitals Vault, you have access to a comprehensive range of biomarker tests.
A Glucose 6 Phosphate Dehydrogenase (G6PD) quantitative test measures how much G6PD enzyme activity is present in your red blood cells. This matters because G6PD helps protect red blood cells from oxidative stress.
If your activity is low, certain medications, infections, or foods can trigger red blood cell breakdown (hemolysis), which can cause anemia, jaundice, and dark urine. A quantitative result helps you and your clinician estimate risk and plan safer choices.
This test is often ordered before specific drugs are prescribed, after an unexplained hemolytic episode, or when there is a family or ancestry-related risk of G6PD deficiency.
Do I need a Glucose 6 Phosphate Dehydrogenase Quantitative test?
You may want a G6PD quantitative test if you have had signs of hemolysis or anemia that were hard to explain, such as sudden fatigue, shortness of breath, pale skin, yellowing of the eyes (jaundice), or tea-colored urine—especially after an illness or a new medication.
This test is also commonly used as a safety screen before medications that can trigger hemolysis in people with low G6PD activity. Examples include certain antimalarials (such as primaquine or tafenoquine), dapsone, rasburicase, and some other oxidant drugs. If you are planning travel, starting a new therapy, or have a clinician considering one of these medications, testing can prevent avoidable complications.
You might also consider testing if G6PD deficiency runs in your family, if you are from an ancestry group where G6PD variants are more common, or if a newborn in your family had significant jaundice. Your result supports clinician-directed decisions; it is not meant to be used as a stand-alone diagnosis or self-treatment plan.
This is a quantitative enzyme activity assay performed in a CLIA-certified laboratory; results should be interpreted with your clinical history and other blood tests.
Lab testing
Order a G6PD quantitative test and schedule your draw when it works for you.
Schedule online, results typically within about a week
Clear reporting and optional clinician context
HSA/FSA eligible where applicable
Get this test with Vitals Vault
Vitals Vault lets you order a G6PD quantitative test directly, then complete your blood draw at a nearby Quest location. This is useful when you need a documented result before starting a medication, or when you want to clarify whether a prior reaction could have been hemolysis.
After your results post, you can use PocketMD to review what “low,” “in range,” or “high” activity typically means and what follow-up labs are commonly paired with G6PD testing. If your situation calls for broader context—such as confirming hemolysis or checking anemia severity—you can add companion labs and retest when it makes sense.
Because G6PD activity can be temporarily misleading around a hemolytic event, having an easy path to repeat testing through Vitals Vault can help you and your clinician confirm the pattern over time.
- Order online and draw at a Quest location
- PocketMD guidance for next steps and retest timing
- Clear, shareable results for clinician discussions
Key benefits of Glucose 6 Phosphate Dehydrogenase (G6PD) quantitative testing
- Helps identify low G6PD activity that can raise your risk of medication- or illness-triggered hemolysis.
- Supports safer prescribing decisions before drugs known to stress red blood cells (for example, certain antimalarials or dapsone).
- Adds context when you have unexplained anemia, jaundice, or dark urine after an infection or new exposure.
- Provides a measurable activity level (not just “positive/negative”), which can be helpful for risk discussions and documentation.
- Guides whether repeat testing is needed after a recent hemolytic episode or transfusion, when results can be harder to interpret.
- Pairs well with hemolysis and anemia labs (CBC, reticulocytes, bilirubin, LDH, haptoglobin) to clarify what is happening.
- Creates a baseline you can store and reference in PocketMD when new medications or travel plans come up.
What is Glucose 6 Phosphate Dehydrogenase (G6PD)?
Glucose 6 Phosphate Dehydrogenase (G6PD) is an enzyme inside your red blood cells that helps generate NADPH, a molecule that protects cells from oxidative damage. Red blood cells are especially dependent on this pathway because they do not have many backup systems to handle oxidative stress.
When G6PD activity is low, red blood cells can be damaged more easily. Under stress—such as certain infections, medications, or exposures—those cells may break down faster than your body can replace them. This breakdown is called hemolysis, and it can lead to hemolytic anemia and jaundice.
A “quantitative” G6PD test measures enzyme activity level in the blood sample. It is different from genetic testing, which looks for variants in the G6PD gene. Activity testing reflects what your red blood cells are doing right now, which is clinically useful, but it can be affected by timing and recent events.
Why G6PD deficiency is often discussed as a safety issue
Many people with low G6PD activity feel completely well until an oxidative trigger occurs. That is why screening is often done before a known trigger medication is started, or after a suspicious episode, rather than as part of routine wellness testing for everyone.
Quantitative activity testing vs. genetic testing
An activity test tells you how much enzyme function is present in your circulating red blood cells. Genetic testing can help explain the underlying variant and may be useful in complex cases, but it does not always predict real-world activity perfectly, and it may not capture all variants depending on the method.
What do my Glucose 6 Phosphate Dehydrogenase (G6PD) results mean?
Low G6PD activity
Low activity suggests your red blood cells have reduced ability to handle oxidative stress, which increases the chance of hemolysis with certain triggers. If you are currently ill, recently had hemolysis, or recently received a blood transfusion, your result can look higher than your baseline because younger red blood cells (reticulocytes) have more G6PD activity. In that setting, your clinician may recommend repeating the test after recovery (often several weeks) and pairing it with hemolysis labs to confirm what is happening.
In-range (expected) G6PD activity
An in-range result usually means your red blood cells have typical protection against oxidative stress from the G6PD pathway. It lowers the likelihood that G6PD deficiency is the main reason for a hemolytic episode, but it does not rule out other causes of anemia or hemolysis. If symptoms persist, your clinician may look at a complete blood count (CBC), reticulocyte count, bilirubin, LDH, and haptoglobin to find the source.
High G6PD activity
High activity is usually not a disease finding by itself. It can occur when your body is making more new red blood cells (reticulocytosis), such as after blood loss or recovery from hemolysis, because younger cells tend to have higher enzyme activity. The most important question is whether the value fits your clinical timing and whether other labs show anemia or hemolysis.
Factors that influence G6PD results
Timing matters: testing during or soon after hemolysis can underestimate deficiency because the most enzyme-poor cells may have already broken down, while the remaining younger cells read higher. Recent transfusion can also raise measured activity by adding donor red blood cells. Lab methods and reference ranges vary, and some people (including many heterozygous females) can have intermediate activity that requires careful interpretation alongside symptoms, triggers, and follow-up labs.
What’s included
- Glucose-6-Phosphate Dehydrogenase
Frequently Asked Questions
What does a G6PD quantitative test measure?
It measures the activity of the G6PD enzyme in your red blood cells. The activity level helps estimate how well your red blood cells can handle oxidative stress and whether you may be at risk for hemolysis with certain triggers.
Do I need to fast for a G6PD test?
Fasting is usually not required for a G6PD quantitative test. If you are getting other labs at the same time (like a lipid panel or glucose testing), follow the instructions for those tests.
Can a recent hemolytic episode make my G6PD result inaccurate?
Yes. During or shortly after hemolysis, the most vulnerable red blood cells may already be gone, and your blood may contain a higher proportion of young red blood cells that have higher G6PD activity. That can make deficiency look milder than it is, so repeat testing after recovery is sometimes recommended.
How long after a blood transfusion should I wait to test G6PD?
A transfusion can temporarily raise measured G6PD activity because donor red blood cells contribute to the result. Many clinicians prefer waiting several weeks (often up to a few months, depending on circumstances) so your circulating red blood cells better reflect your own baseline; your clinician can advise based on timing and urgency.
What medications or exposures are commonly discussed with G6PD deficiency?
The exact list depends on your clinician and the situation, but commonly discussed triggers include certain antimalarials (such as primaquine or tafenoquine), dapsone, rasburicase, and other oxidant drugs. Infections can also trigger hemolysis, and fava beans are a classic dietary trigger in some people.
If my G6PD is low, what other labs help confirm hemolysis?
A complete blood count (CBC) with hemoglobin/hematocrit, reticulocyte count, bilirubin (especially indirect), lactate dehydrogenase (LDH), and haptoglobin are commonly used to evaluate anemia and hemolysis. Your clinician may also consider a peripheral smear and other tests depending on the pattern.